The N676D and G697R mutations in the kinase domain of FLT3 confer resistance to the inhibitor AC220

Haematologica. 2012 Nov;97(11):1773-4. doi: 10.3324/haematol.2012.069781. Epub 2012 Aug 8.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Substitution
  • Benzothiazoles / pharmacology*
  • Cell Line, Tumor
  • Drug Resistance, Neoplasm / genetics*
  • Female
  • Humans
  • Leukemia, Myeloid, Acute / drug therapy
  • Leukemia, Myeloid, Acute / enzymology
  • Leukemia, Myeloid, Acute / genetics*
  • Male
  • Mutation, Missense*
  • Phenylurea Compounds / pharmacology*
  • Protein Kinase Inhibitors / pharmacology*
  • Protein Structure, Tertiary
  • fms-Like Tyrosine Kinase 3 / antagonists & inhibitors*
  • fms-Like Tyrosine Kinase 3 / genetics*
  • fms-Like Tyrosine Kinase 3 / metabolism

Substances

  • Benzothiazoles
  • Phenylurea Compounds
  • Protein Kinase Inhibitors
  • quizartinib
  • FLT3 protein, human
  • fms-Like Tyrosine Kinase 3